| Course | NSG 318 Introduction to Pharmacology |
|---|---|
| Topic | Topic 3 |
| Paper type | Drug class profile |
| Length | About 990 words, 3 pages |
| Format | APA 7 student paper |
| School | Grand Canyon University (GCU) |
| Program | BSN |
| Updated | October 2026 |
Free sample paper for NSG 318 Topic 3
Drug Class Profile: ACE Inhibitors, From the Suffix on the Medication Record to the Swollen Lip Nobody Should Miss
[Author Name]
College of Nursing and Health Care Professions, Grand Canyon University
NSG-318: Introduction to Pharmacology
Topic 3 Assignment
[Instructor Name]
September 21, 2026
Drug Class Profile: ACE Inhibitors, From the Suffix on the Medication Record to the Swollen Lip Nobody Should Miss
Recognizing the Class
Angiotensin-converting enzyme inhibitors share a generic name ending in -pril: lisinopril, enalapril, benazepril, ramipril, captopril and others. A nurse who sees an unfamiliar name ending in -pril on a medication record can recognize the class, and with it the expected effects, the adverse effects and the monitoring, without memorizing each drug separately. This profile explains what the whole class has in common, then applies it to a composite patient. The members differ mainly in how often they are taken and how they are cleared, not in how they work (Burchum & Rosenthal, 2022).
Mechanism
The renin-angiotensin-aldosterone system helps the body maintain blood pressure and fluid volume. When the kidneys sense low perfusion, they release renin, which converts angiotensinogen to angiotensin I. Angiotensin-converting enzyme, found mainly in the lungs, converts angiotensin I to angiotensin II, a powerful vasoconstrictor that also stimulates the release of aldosterone, which causes the kidneys to retain sodium and water and excrete potassium. ACE inhibitors block that conversion. With less angiotensin II, blood vessels relax and blood pressure falls, and with less aldosterone, the kidneys excrete more sodium and water and retain more potassium. The same enzyme also breaks down bradykinin, a substance that dilates blood vessels and irritates airways, so ACE inhibitors allow bradykinin to accumulate. Almost every expected and adverse effect of the class follows from two consequences of blocking one enzyme: less angiotensin II and more bradykinin.
Expected Effects and Uses
Lower angiotensin II lowers blood pressure, which is why ACE inhibitors treat hypertension. Reduced vasoconstriction and aldosterone lower the workload of a failing heart and limit the harmful remodeling that follows a heart attack, which is why they are used in heart failure with reduced ejection fraction and after myocardial infarction. In the kidney, angiotensin II constricts the efferent arteriole leaving the glomerulus; blocking it lowers pressure inside the glomerulus and reduces protein leakage, which is why ACE inhibitors or angiotensin receptor blockers are recommended to slow kidney disease in people with diabetes and albuminuria (Kidney Disease: Improving Global Outcomes Diabetes Work Group, 2022).
Adverse Effects, Derived
First-dose hypotension follows from sudden vasodilation, especially in patients who are dehydrated or taking diuretics. Hyperkalemia follows from reduced aldosterone, since the kidneys hold on to potassium. A rise in serum creatinine can occur when the drug lowers glomerular pressure; a modest rise is expected, but a large rise may signal that the kidneys depend on angiotensin II to maintain filtration, as in renal artery stenosis. A dry, persistent cough follows from accumulated bradykinin in the airways and affects a meaningful minority of patients. Angioedema, swelling of the lips, tongue, face or throat, is the most dangerous adverse effect; it is also linked to bradykinin, can occur at any time during treatment, even after years, and can obstruct the airway. Its reported incidence is higher in Black patients than in White patients (Brown et al., 1996). Finally, ACE inhibitors can cause fetal harm when used during pregnancy, particularly in the second and third trimesters, and carry a boxed warning for fetal toxicity.
Applying the Profile
Mrs. R. J., a composite 58-year-old school librarian whose diabetes, hypertension and albuminuria were found at a work health screening, is started on lisinopril 10 milligrams daily. She also takes hydrochlorothiazide. Before the first dose, the nurse checks her blood pressure, her potassium and creatinine, and asks whether she could be pregnant, since she is perimenopausal and has not had a period for eight months. Because she takes a diuretic, the nurse advises her to take the first dose at bedtime and to rise slowly. The nurse teaches her to report dizziness or fainting, to avoid potassium supplements and salt substitutes made with potassium chloride unless her provider approves them, and to expect a follow-up blood test for potassium and creatinine within one to two weeks. She also teaches, plainly and without alarm, that any swelling of the lips, tongue, face or throat, or any difficulty breathing or swallowing, means calling 911 and stopping the drug, even if she has taken it without trouble for a long time.
Interactions Worth Knowing for the Whole Class
Because every ACE inhibitor works the same way, their important interactions also apply across the class. Potassium-sparing diuretics, potassium supplements and potassium-based salt substitutes add to the rise in potassium caused by reduced aldosterone, and the combination can produce dangerous hyperkalemia, especially in patients with kidney disease. Nonsteroidal anti-inflammatory drugs reduce the blood pressure effect and, combined with a diuretic, raise the risk of acute kidney injury. Lithium levels can rise because ACE inhibitors reduce its excretion. And combining an ACE inhibitor with an angiotensin receptor blocker or a direct renin inhibitor, blocking the same system at two points, increases hyperkalemia and kidney injury without adding meaningful benefit for most patients, so the combination is generally avoided. A nurse reviewing a medication list can scan for these pairings as soon as she recognizes the -pril suffix.
When the Cough Comes
Six weeks later, Mrs. J. reports a tickling dry cough that keeps her awake. She has no fever or sputum. The profile predicts the cause: bradykinin accumulation. The cough is not dangerous, but it is a common reason patients stop taking ACE inhibitors without telling anyone. The nurse reports it to the provider, who may switch her to an angiotensin receptor blocker, a drug that blocks the effect of angiotensin II at its receptor without affecting bradykinin and therefore rarely causes cough. The nurse also documents the cough as an adverse effect so that the class is not restarted by another prescriber. A nurse who understands the mechanism can explain to Mrs. J. why the new drug should help with her kidneys in the same way while sparing her the cough, which makes it more likely she will take it.
References
Brown, N. J., Ray, W. A., Snowden, M., & Griffin, M. R. (1996). Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clinical Pharmacology & Therapeutics, 60(1), 8-13. https://doi.org/10.1016/S0009-9236(96)90161-7
Burchum, J. R., & Rosenthal, L. D. (2022). Lehne's pharmacology for nursing care (11th ed.). Elsevier.
Kidney Disease: Improving Global Outcomes Diabetes Work Group. (2022). KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney International, 102(5S), S1-S127. https://doi.org/10.1016/j.kint.2022.06.008
What the NSG 318 Topic 3 instructions ask for
Topic 3 in NSG-318 asks students to profile a drug class. Strong profiles explain how to recognize the class, such as by a shared suffix, then describe the mechanism and derive expected effects, uses and adverse effects from it, including the dangerous effects a nurse must not miss. Students should list interactions that apply across the class, apply the profile to a patient so it becomes practical and show how a nurse would handle a common problem, such as a dry cough, in that patient. Dosing usually belongs elsewhere, and the number of drugs from the class to name should follow the prompt.
How this NSG 318 Topic 3 example is built
The profile is organized around what every member of the class has in common. It opens by showing how the shared suffix, pril, lets a nurse recognize the class on an unfamiliar medication record. The mechanism follows in one paragraph: blocking the conversion of angiotensin I to angiotensin II lowers vasoconstriction and aldosterone, and slowing bradykinin breakdown accounts for the dry cough. From there the expected and serious effects are derived rather than listed: first-dose hypotension, a rising potassium, changes in kidney function, and angioedema as the rare reaction that means holding the drug and reporting at once. Nursing checks sit beside each effect, blood pressure before the dose and potassium and creatinine results reviewed. A short passage names what differs among members, mainly duration of action, and why that matters less than the shared profile.
NSG 318 Topic 3 rubric: what Excellent looks like
Faculty reward a class profile that a nurse could use on an unfamiliar drug. An Excellent paper teaches recognition by the -pril suffix and derives effects from blocking angiotensin II formation. Credit goes to adverse effects derived from mechanism, such as hyperkalemia from reduced aldosterone and angioedema from bradykinin, citing Brown and colleagues. The rubric values class-wide interactions, such as potassium-sparing diuretics, and KDIGO guidance on kidney protection. Strong papers apply the profile to Mrs. J. Top marks go to handling the six-week cough correctly.
NSG 318 Topic 3 help before you submit
Class profiles lose their marks when they turn back into drug cards. Three agents described one after another, each with its own dose range and side effect list, show effort without showing the shared mechanism the rubric is typically checking for. The cough is a telling case: papers that list it without explaining bradykinin cannot say why switching to a receptor blocker usually helps. A second loss comes from treating every adverse effect as equal, since the course expects angioedema to be separated clearly from a tolerable nuisance. Laboratory monitoring reduced to a bare instruction to check labs, with no value named and no reason given, earns little. Graders also notice doses copied from a reference into a class paper, where they add risk and no reasoning. Stronger profiles let the mechanism generate every nursing check in the document.
Get an NSG-318 Topic 3 example written to your instructions
Send your NSG-318 Topic 3 instructions and rubric, and name the drug class your section assigns. We write a custom example to them, built on what the class has in common and the checks that follow, and deliver it within 24 to 48 hours. The first one is free. It is coursework support, with no dose in it meant for real use.
More NSG 318 papers and BSN samples
- NSG 318 Topic 1: Pharmacokinetics Application Paper
- NSG 318 Topic 2: Receptor Mechanism Paper
- NSG 318 Topic 4: Adverse Effect Analysis
- NSG 318 Topic 5: Drug Interaction DQ
- NSG 318 Topic 6: Special Population Dosing Paper
- NSG 318 Topic 7: Medication Administration Case Study
- NSG 318 Topic 8: Medication Teaching Plan
- NSG 320 Topic 3: Heart Failure Priorities Paper
- NSG 310 Topic 3: Nurse Practice Act Analysis
- NSG 322 Topic 3: Mental Status Examination Note
- NSG 300 Topic 3: Narrative Nursing Note
NSG 318 Topic 3 questions, answered
Why profile a class instead of one drug?
Because the class carries over to agents you have not met. Every ACE inhibitor shares the same mechanism, so the cough, the potassium effect and the risk of angioedema apply across the family. Learning the class once and noting the few members that behave unusually covers far more ground than memorizing individual drugs, which is why many NSG-318 sections assign classes directly.
Should the profile include dosing?
Usually not. Dosing belongs in a class paper only when the prompt requires it, because a class profile is about mechanism, effects and nursing responsibilities, and doses vary by agent, indication and patient. Where a prompt does require a dose, cite a current drug reference and present it as reference material for the assignment. The example here leaves doses out entirely and keeps its attention on what the nurse checks.
How many drugs from the class should appear?
Follow the prompt. When it is open, naming two or three members to illustrate the shared suffix and any notable difference, such as duration, is usually enough. The weight of the paper belongs on the mechanism and the checks it predicts, and spending paragraphs on separate agents tends to rebuild the very list the class approach was meant to replace.
Where can I find a free NSG 318 Topic 3 sample paper?
The class profile for NSG 318 Topic 3 covers recognizing the class, mechanism, expected effects and uses, adverse effects derived, applying the profile, class-wide interactions and when the cough comes. Post your NSG 318 Topic 3 prompt and get a free paper.
Why profile a class instead of one drug in NSG 318 Topic 3?
Because the class carries the mechanism. A nurse who knows ACE inhibitors can reason about any -pril drug, even one never seen before.